This inventor holds 3 USPTO granted patents. Top assignee: Neurosearch A/s. Active years: 1997-2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Ballerup, DK (2001)
- Ringsted, DK (1997 - 2002)
Company Filing History:
Years Active: 1997-2002
Title: Ove Pedersen: Innovator in Pharmaceutical Chemistry
Introduction
Ove Pedersen is a notable inventor based in Ringsted, Denmark. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target chloride channels. With a total of three patents to his name, Pedersen's work is recognized for its potential therapeutic applications.
Latest Patents
One of Ove Pedersen's latest patents is focused on phenyl derivatives containing an acidic group, which are useful as chloride channel blockers. This patent describes compounds that can be utilized in treating various diseases and disorders responsive to the blockage of chloride channels. Another significant patent involves substituted phenyl derivatives that are beneficial in the treatment of sickle-cell anemia. These innovations highlight Pedersen's commitment to advancing medical science through his research.
Career Highlights
Ove Pedersen is associated with Neurosearch A/S, a company dedicated to developing innovative treatments for neurological and psychiatric disorders. His work at Neurosearch has allowed him to explore the therapeutic potential of his patented compounds, contributing to the advancement of medical treatments.
Collaborations
Throughout his career, Ove Pedersen has collaborated with esteemed colleagues, including Palle Christophersen and Søren-Peter Olesen. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.
Conclusion
Ove Pedersen's contributions to pharmaceutical chemistry through his innovative patents and collaborations underscore his role as a key figure in the field. His work continues to pave the way for advancements in medical treatments, particularly in addressing critical health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile